Smiths Medical ASD Inc. recalls CADD Administration Set, List Numbers: a) REF 21-7346-24; b) REF 21-7363-24

Recalled February 8, 2023 · FDA recall Z-0962-2023 · Smiths Medical ASD

Hazard

There are two potential issues with CADD Infusion System Infusion Sets: (1) Lack of Delivery or Underdelivery related to Tubing Occlusion and (2) False "No Disposable Attached (NDA)" Alarms · FDA Class I

Units

1616714 units

Sold at

Worldwide Distribution: US (nationwide) and OUS countries of: CH, CA, ES, FR, AT, BE, IT, DK, NO, EE, DE, NL, AU, GB, SE, PL, SA, IN, IL, PT, CZ, IE, NZ, LU, SI, ZA, BM, SG, MQ, CL, LB, MY, HU, JP, TW, and CN

Description

There are two potential issues with CADD Infusion System Infusion Sets: (1) Lack of Delivery or Underdelivery related to Tubing Occlusion and (2) False "No Disposable Attached (NDA)" Alarms

Product

CADD Administration Set, List Numbers: a) REF 21-7346-24; b) REF 21-7363-24

Manufacturer(s)

Smiths Medical ASD Inc.

Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →